Tidal Trust II - Defiance Daily Target 2x Long Uranium ETF EBIT

As of the most recent data (March 2019), URAX shows a EBIT of $170M. That compares with $190M in the prior-year period — down 10.3% year over year. That is above the sector sector average of $-69M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, URAX's EBIT is now $170M (was $190M) — a 10.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Tidal Trust II - Defiance Daily Target 2x Long Uranium ETF is outperforming or lagging.

The its sector sector average EBIT is about $-69M. Tidal Trust II - Defiance Daily Target 2x Long Uranium ETF is at $170M, which is higher that average. That is roughly 344.5% above the sector mean. Use the comparison chart on this page to see how URAX stacks up against individual peers as well.

Tracking URAX's ebit over time shows whether Tidal Trust II - Defiance Daily Target 2x Long Uranium ETF is scaling, shrinking, or reshaping that part of the business. The current reading is $170M That compares with $190M in the prior-year period — down 10.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Tidal Trust II - Defiance Daily Target 2x Long Uranium ETF's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $170M) with ownership activity and broader fundamentals.